United States· US:53436-084_3e4b6452-1c7c-4f58-aee4-12fb185aaa83
VELTASSA
A medicinal product containing patiromer, registered in United States by Vifor Pharma, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- PATIROMER
- Manufacturer
- Vifor Pharma, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc1153436-084-04
- ndc1153436-084-30
- ndc1153436-084-92
- ndc1153436084044 PACKET in 1 CARTON (53436-084-04) / 1 POWDER, FOR SUSPENSION in 1 PACKET (53436-084-01)
- ndc11534360843030 PACKET in 1 CARTON (53436-084-30) / 1 POWDER, FOR SUSPENSION in 1 PACKET (53436-084-01)
- ndc1153436084924 PACKET in 1 CARTON (53436-084-92) / 1 POWDER, FOR SUSPENSION in 1 PACKET (53436-084-91)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Patiromer in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaVELTASSAVIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD
- SpainVELTASSA 8,4 G POLVO PARA SUSPENSION ORALVifor Fresenius Medical Care Renal Pharma France
- NorwayVeltassaVifor Fresenius Medical Care Renal Pharma France
- PolandVeltassaVifor Fresenius Medical Care Renal Pharma France
- SwedenVeltassa 8,4 g Pulver till oral suspensionVifor Fresenius Medical Care Renal Pharma France
- SwitzerlandVeltassa 16.8 g, Pulver für orale SuspensionVifor Fresenius Medical Care Renal Pharma Ltd.
- ItalyVELTASSA*orale polv 30 bust 16,8 gVIFOR FRESENIUS M.C.R.P.FRANCE
- Japanパチロマーソルビテクスカルシウムゼリア新薬工業
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Veltassa
- Liechtenstein · Veltassa
- Norway · Veltassa
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2b149d77-c4de-4bc8-a2b5-f9b0af2e7fa0 GET /v1/drugs/2b149d77-c4de-4bc8-a2b5-f9b0af2e7fa0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "8.4",
"substance": "PATIROMER",
"productndc": "53436-084",
"dosage_form": "POWDER, FOR SUSPENSION",
"dea_schedule": null,
"strength_unit": "g/1",
"application_number": "NDA205739",
"marketing_category": "NDA"
}See everything about patiromer.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.